ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Health Disparities Center Describes “Think Tank” Projects For Policy Change.

April 27, 2001

Radiation Therapy Combination Better For Treating Cancer Spread To Brain

May 28, 2004

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994

Roswell Park Researchers Advocate HPV Vaccination For Boys As Well As Girls

May 29, 2009

NEJM Papers Reaffirm Results Of Lumpectomy Trial; Audit Verifies Data

December 8, 1995

Congress Passes Biomedical Research Authorization, Regular Appropriations Bill; NCI Gets $1.183 Billion

October 19, 1984